392 related articles for article (PubMed ID: 15627894)
1. Clinicopathological significance of stromal myofibroblasts in invasive ductal carcinoma of the breast.
Yazhou C; Wenlv S; Weidong Z; Licun W
Tumour Biol; 2004; 25(5-6):290-5. PubMed ID: 15627894
[TBL] [Abstract][Full Text] [Related]
2. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
Barth PJ; Ebrahimsade S; Ramaswamy A; Moll R
Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601
[TBL] [Abstract][Full Text] [Related]
3. There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions.
Chauhan H; Abraham A; Phillips JR; Pringle JH; Walker RA; Jones JL
J Clin Pathol; 2003 Apr; 56(4):271-6. PubMed ID: 12663638
[TBL] [Abstract][Full Text] [Related]
4. Consistent lack of CD34-positive stromal cells in the stroma of malignant breast lesions.
Kuroda N; Jin YL; Hamauzu T; Toi M; Miyazaki E; Hiroi M; Moriki T; Enzan H
Histol Histopathol; 2005 Jul; 20(3):707-12. PubMed ID: 15944918
[TBL] [Abstract][Full Text] [Related]
5. Distribution of myofibroblast cells and microvessels around invasive ductal carcinoma of the breast and comparing with the adjacent range of their normal-to-DCIS zones.
Dabiri S; Talebi A; Shahryari J; Meymandi MS; Safizadeh H
Arch Iran Med; 2013 Feb; 16(2):93-9. PubMed ID: 23360631
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic significance of the immunoexpression of CD34 and smooth muscle cell actin in benign and malignant tumors of the breast.
Cîmpean AM; Raica M; Nariţa D
Rom J Morphol Embryol; 2005; 46(2):123-9. PubMed ID: 16286998
[TBL] [Abstract][Full Text] [Related]
7. The assessment of angiogenesis and fibroblastic stromagenesis in hyperplastic and pre-invasive breast lesions.
Pavlakis K; Messini I; Vrekoussis T; Yiannou P; Keramopoullos D; Louvrou N; Liakakos T; Stathopoulos EN
BMC Cancer; 2008 Apr; 8():88. PubMed ID: 18384688
[TBL] [Abstract][Full Text] [Related]
8. Prognostic relevance of the loss of stromal CD34 positive fibroblasts in invasive lobular carcinoma of the breast.
Westhoff CC; Jank P; Jacke CO; Albert US; Ebrahimsade S; Barth PJ; Moll R
Virchows Arch; 2020 Nov; 477(5):717-724. PubMed ID: 32435886
[TBL] [Abstract][Full Text] [Related]
9. Variable stromal periductular expression of CD34 and smooth muscle actin (SMA) in intraductal carcinoma of the breast.
Catteau X; Simon P; Vanhaeverbeek M; Noël JC
PLoS One; 2013; 8(3):e57773. PubMed ID: 23469238
[TBL] [Abstract][Full Text] [Related]
10. [Changes of fibroblast immunophenotype and their clinical significance in stromal remodeling of breast tumors].
Hua X; Huang X; Liao Z; Xian Q; Yu L
Zhonghua Zhong Liu Za Zhi; 2014 Nov; 36(11):834-8. PubMed ID: 25620480
[TBL] [Abstract][Full Text] [Related]
11. CD34+ fibrocytes, alpha-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx.
Barth PJ; Schenck zu Schweinsberg T; Ramaswamy A; Moll R
Virchows Arch; 2004 Mar; 444(3):231-4. PubMed ID: 14758552
[TBL] [Abstract][Full Text] [Related]
12. Stromal remodeling and SPARC (secreted protein acid rich in cysteine) expression in invasive ductal carcinomas of the breast.
Barth PJ; Moll R; Ramaswamy A
Virchows Arch; 2005 May; 446(5):532-6. PubMed ID: 15838642
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD34, alpha-smooth muscle actin, and transforming growth factor beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the larynx and hypopharynx.
Kojc N; Zidar N; Vodopivec B; Gale N
Hum Pathol; 2005 Jan; 36(1):16-21. PubMed ID: 15712177
[TBL] [Abstract][Full Text] [Related]
14. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
15. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas.
Nielsen BS; Rank F; López JM; Balbin M; Vizoso F; Lund LR; Danø K; López-Otín C
Cancer Res; 2001 Oct; 61(19):7091-100. PubMed ID: 11585740
[TBL] [Abstract][Full Text] [Related]
16. The distribution and role of myofibroblasts and CD34-positive stromal cells in normal pancreas and various pancreatic lesions.
Kuroda N; Toi M; Nakayama H; Miyazaki E; Yamamoto M; Hayashi Y; Hiroi M; Enzan H
Histol Histopathol; 2004 Jan; 19(1):59-67. PubMed ID: 14702172
[TBL] [Abstract][Full Text] [Related]
17. Myofibroblastic stromal reaction and lymph node status in invasive breast carcinoma: possible role of the TGF-β1/TGF-βR1 pathway.
Catteau X; Simon P; Noël JC
BMC Cancer; 2014 Jul; 14():499. PubMed ID: 25011545
[TBL] [Abstract][Full Text] [Related]
18. CD34+ fibrocytes in tubular carcinomas and radial scars of the breast.
Ramaswamy A; Moll R; Barth PJ
Virchows Arch; 2003 Oct; 443(4):536-40. PubMed ID: 12898244
[TBL] [Abstract][Full Text] [Related]
19. [Expressions of D2-40 and CD34 in invasive ductal carcinoma of the breast and the clinical implications].
Zhen LF; Ye CS; Liu MF; Ding GP; Liao JJ
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jul; 30(7):1548-51. PubMed ID: 20650763
[TBL] [Abstract][Full Text] [Related]
20. The Significance of the Stromal Response in Breast Cancer: An Immunohistochemical Study of Myofibroblasts in Primary and Metastatic Breast Cancer.
Roozdar A; Hayes MM; Pourseyedei B; Zeinalinejad H; Shamsi Meymandi M; Dabiri B; Dabiri S
Arch Iran Med; 2018 May; 21(5):185-190. PubMed ID: 29738261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
